BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1306@pharmaconomics
DTSTAMP:20260707T034447Z
DTSTART;VALUE=DATE:20260227
DTEND;VALUE=DATE:20260228
SUMMARY:ASND Approval — YUVIWEL
DESCRIPTION:A final FDA approval decision on YUVIWEL for achondroplasia with open epiphyses is expected Feb 27\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1612042/000119312526084021/d116890d6k.htm\n\nTrack it: https://www.pharmaconomics.com/e/1306
URL:https://www.pharmaconomics.com/e/1306
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ASND catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR